• 中文核心期刊要目总览
  • 中国科技核心期刊
  • 中国科学引文数据库(CSCD)
  • 中国科技论文与引文数据库(CSTPCD)
  • 中国学术期刊文摘数据库(CSAD)
  • 中国学术期刊(网络版)(CNKI)
  • 中文科技期刊数据库
  • 万方数据知识服务平台
  • 中国超星期刊域出版平台
  • 国家科技学术期刊开放平台
  • 荷兰文摘与引文数据库(SCOPUS)
  • 日本科学技术振兴机构数据库(JST)
李玲芝, 彭缨, 牛超, 高品一, 黄肖霄, 毛新良, 宋少江. 山楂核中具有抗肿瘤活性化合物的分离[J]. 中国天然药物, 2013, 11(4): 411-414.
引用本文: 李玲芝, 彭缨, 牛超, 高品一, 黄肖霄, 毛新良, 宋少江. 山楂核中具有抗肿瘤活性化合物的分离[J]. 中国天然药物, 2013, 11(4): 411-414.
LI Ling-Zhi, PENG Ying, NIU Chao, GAO Pin-Yi, HUANG Xiao-Xiao, MAO Xin-Liang, SONG Shao-Jiang. Isolation of cytotoxic compounds from the seeds of Crataegus pinnatifida[J]. Chinese Journal of Natural Medicines, 2013, 11(4): 411-414.
Citation: LI Ling-Zhi, PENG Ying, NIU Chao, GAO Pin-Yi, HUANG Xiao-Xiao, MAO Xin-Liang, SONG Shao-Jiang. Isolation of cytotoxic compounds from the seeds of Crataegus pinnatifida[J]. Chinese Journal of Natural Medicines, 2013, 11(4): 411-414.

山楂核中具有抗肿瘤活性化合物的分离

Isolation of cytotoxic compounds from the seeds of Crataegus pinnatifida

  • 摘要: 目的:对山楂核的化学成分及生物活性进行研究。方法:运用大孔吸附树脂D101,硅胶,ODS和制备高效液相色谱等方法分离化合物,通过多种波谱方法进行结构鉴定。此外,还对化合物进行了OPM2和RPMI-8226两组细胞株的细胞毒活性测试。结果:从山楂核中得到4个化合物:(7S,8S)-4-2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-(hydroxymethyl) ethoxy-3,5-dimethoxybenzaldehyde(1),(+)-balanophonin(2),erythro-guaiacylglycerol--coniferyl aldehyde ether(3),buddlenol A(4)。结论:化合物1为一新降木脂素。化合物2-4为属内首次分离得到。活性测试结果表明化合物1-4的抗肿瘤活性不明显。

     

    Abstract: AIM:To study the chemical constituents and bioactivity of the seeds of Crataegus pinnatifida.METHODS:The chemical constituents were isolated and purified by macroporous adsorptive resin D101,silica gel,and ODS column chromatography,and preparative HPLC.Their structures were elucidated on the basis of spectroscopic methods.In addition,the cytotoxic activities of compounds 1-4 were investigated on OPM2 and RPMI-8226 cells.RESULTS:Four compounds were obtained and their structures were identified as(7S,8S)-4-2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-(hydroxymethyl) ethoxy-3,5-dimethoxybenzaldehyde(1),(+)-balanophonin(2),erythro-guaiacylglycerol--coniferyl aldehyde ether(3),buddlenol A(4).CONCLUSION:Compound 1 is a novel norlignan,while compounds 1-4 exhibited marginal inhibition on the proliferation of OPM2 and RPMI-8226 cells.

     

/

返回文章
返回